InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the complete record of transactions filed by Mainolfi Nello. Director active across 1 company, notably Kymera Therapeutics, Inc.. In total, 2 filings have been published. Activity tracked since 1 July 2026. The latest transaction was disclosed on 7 July 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations